Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
May-2021 Volume 21 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2021 Volume 21 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Kuwanon G protects HT22 cells from advanced glycation end product-induced damage

  • Authors:
    • Wen-Jun Gan
    • Chen-Lin Gao
    • Wen-Qian Zhang
    • Jun-Ling Gu
    • Ting-Ting Zhao
    • Heng-Li Guo
    • Hua Zhou
    • Yong Xu
    • Li-Li Yu
    • Li-Fang Li
    • Ding-Kun Gui
    • You-Hua Xu
  • View Affiliations / Copyright

    Affiliations: Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao SAR 999078, P.R. China, Department of Endocrinology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 510500, P.R. China, Department of Nephrology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, P.R. China
    Copyright: © Gan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 425
    |
    Published online on: February 25, 2021
       https://doi.org/10.3892/etm.2021.9869
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The incidence of diabetic encephalopathy is increasing as the population ages. Evidence suggests that formation and accumulation of advanced glycation end products (AGEs) plays a pivotal role in disease progression, but limited research has been carried out in this area. A previous study demonstrated that Kuwanon G (KWG) had significant anti-oxidative stress and anti-inflammatory properties. As AGEs are oxidative products and inflammation is involved in their generation it is hypothesized that KWG may have effects against AGE-induced neuronal damage. In the present study, mouse hippocampal neuronal cell line HT22 was used. KWG was shown to significantly inhibit AGE-induced cell apoptosis in comparison with a control treatment, as determined by both MTT and flow cytometry. Compared with the AGEs group, expression of pro-apoptotic protein Bax was reduced and expression of anti-apoptotic protein Bcl-2 was increased in the AGEs + KWG group. Both intracellular and extracellular levels of acetylcholine and choline acetyltransferase were significantly elevated after KWG administration in comparison with controls whilethe level of acetylcholinesterase decreased. These changes in protein expression were accompanied by increased levels of superoxide dismutase and glutathione peroxidase synthesis and reduced production of malondialdehyde and reactive oxygen species. Intracellular signaling pathway protein levels were determined by western blot and immunocytochemistry. KWG administration was found to prevent AGE-induced changes to the phosphorylation levels of Akt, IκB-α, glycogen synthase kinase 3 (GSK3)-α and β, p38 MAPK and NF-κB p65 suggesting a potential neuroprotective effect of KWG against AGE-induced damage was via the PI3K/Akt/GSK3αβ signaling pathway. The findings of the present study suggest that KWG may be a potential treatment for diabetic encephalopathy.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Markowicz-Piasecka M, Sikora J, Szydłowska A, Skupień A, Mikiciuk-Olasik E and Huttunen KM: Metformin - a future therapy for neurodegenerative diseases: Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla. Pharm Res. 34:2614–2627. 2017.PubMed/NCBI View Article : Google Scholar

2 

Gireesh G, Kumar TP, Mathew J and Paulose C: Enhanced muscarinic M1 receptor gene expression in the corpus striatum of streptozotocin-induced diabetic rats. J Biomed Sci. 16(38)2009.PubMed/NCBI View Article : Google Scholar

3 

Saliu JA, Oboh G, Omojokun OS, Rocha JBT, Schetinger MR, Guterries J, Stefanello N, Carvalho F, Schmatz R, Morsch VM, et al: Effect of dietary supplementation of Padauk (Pterocarpus soyauxii) leaf on high fat diet/streptozotocin induced diabetes in rats’ brain and platelets. Biomed Pharmacother. 84:1194–1201. 2016.PubMed/NCBI View Article : Google Scholar

4 

Zhao J, Liu L, Li X, Zhang L, Lv J, Guo X, Chen H and Zhao T: Neuroprotective effects of an Nrf2 agonist on high glucose-induced damage in HT22 cells. Biol Res. 52(53)2019.PubMed/NCBI View Article : Google Scholar

5 

Waslo C, Bourdette D, Gray N, Wright K and Spain R: Lipoic acid and other antioxidants as therapies for multiple sclerosis. Curr Treat Options Neurol. 21(26)2019.PubMed/NCBI View Article : Google Scholar

6 

Eckert GP, Eckert SH, Eckmann J, Hagl S, Muller WE and Friedland K: Olesoxime improves cerebral mitochondrial dysfunction and enhances Aβ levels in preclinical models of Alzheimer's disease. Exp Neurol. 329(113286)2020.PubMed/NCBI View Article : Google Scholar

7 

Balamurugan M, Santharaman P, Madasamy T, Rajesh S, Sethy NK, Bhargava K, Kotamraju S and Karunakaran C: Recent trends in electrochemical biosensors of superoxide dismutases. Biosens Bioelectron. 116:89–99. 2018.PubMed/NCBI View Article : Google Scholar

8 

Jiao Y, Wang Y, Guo S and Wang G: Glutathione peroxidases as oncotargets. Oncotarget. 8:80093–80102. 2017.PubMed/NCBI View Article : Google Scholar

9 

Paudel P, Yu T, Seong SH, Kuk EB, Jung HA and Choi JS: Protein tyrosine phosphatase 1B inhibition and glucose uptake potentials of mulberrofuran G, Albanol B, and Kuwanon G from root bark of Morus alba L. in insulin-resistant HepG2 cells: An in vitro and in silico study. Int J Mol Sci. 19(E1542)2018.PubMed/NCBI View Article : Google Scholar

10 

Nourazarian AR, Kangari P and Salmaninejad A: Roles of oxidative stress in the development and progression of breast cancer. Asian Pac J Cancer Prev. 15:4745–4751. 2014.PubMed/NCBI View Article : Google Scholar

11 

Lee MS, Park WS, Kim YH, Kwon SH, Jang YJ, Han D, Morita K and Her S: Antidepressant-like effects of Cortex Mori Radicis extract via bidirectional phosphorylation of glucocorticoid receptors in the hippocampus. Behav Brain Res. 236:56–61. 2013.PubMed/NCBI View Article : Google Scholar

12 

Guo H, Xu Y, Huang W, Zhou H, Zheng Z, Zhao Y, He B, Zhu T, Tang S and Zhu Q: Kuwanon G preserves LPS-induced disruption of gut epithelial barrier in vitro. Molecules. 21(E1597)2016.PubMed/NCBI View Article : Google Scholar

13 

You S and Kim GH: Protective effect of Mori Cortex radicis extract against high glucose-induced oxidative stress in PC12 cells. Biosci Biotechnol Biochem. 83:1893–1900. 2019.PubMed/NCBI View Article : Google Scholar

14 

Chen Z, Du X, Yang Y, Cui X, Zhang Z and Li Y: Comparative study of chemical composition and active components against α-glucosidase of various medicinal parts of Morus alba L. Biomed Chromatogr. 32(e4328)2018.PubMed/NCBI View Article : Google Scholar

15 

Wei J, Chen JR, Pais EMA, Wang TY, Miao L, Li L, Li LY, Qiu F, Hu LM, Gao XM, et al: Oxyresveratrol is a phytoestrogen exerting anti-inflammatory effects through NF-κB and estrogen receptor signaling. Inflammation. 40:1285–1296. 2017.PubMed/NCBI View Article : Google Scholar

16 

Lee HJ, Lyu H, Koo U, Nam KW, Hong SS, Kim KO, Kim KH, Lee D and Mar W: Protection of prenylated flavonoids from Mori Cortex Radicis (Moraceae) against nitric oxide-induced cell death in neuroblastoma SH-SY5Y cells. Arch Pharm Res. 35:163–170. 2012.PubMed/NCBI View Article : Google Scholar

17 

Ma LL, Yuan YY, Zhao M, Zhou XR, Jehangir T, Wang FY, Xi Y and Bu SZ: Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in high-fat-diet/streptozotocin-induced type 2 diabetes in rats. Chin J Nat Med. 16:411–417. 2018.PubMed/NCBI View Article : Google Scholar

18 

Liu XX, Zhang XW, Wang K, Wang XY, Ma WL, Cao W, Mo D, Sun Y and Li XQ: Kuwanon G attenuates atherosclerosis by upregulation of LXRα-ABCA1/ABCG1 and inhibition of NFκB activity in macrophages. Toxicol Appl Pharmacol. 341:56–63. 2018.PubMed/NCBI View Article : Google Scholar

19 

Kuk EB, Jo AR, Oh SI, Sohn HS, Seong SH, Roy A, Choi JS and Jung HA: Anti-Alzheimer's disease activity of compounds from the root bark of Morus alba L. Arch Pharm Res. 40:338–349. 2017.PubMed/NCBI View Article : Google Scholar

20 

Gong M, Ye S, Li WX, Zhang J, Liu Y, Zhu J, Lv W, Zhang H, Wang J, Lu A, et al: Regulatory function of Pja2 mediated by the P2rx3/P2rx7 axis in mouse hippocampal neuronal cells. Am J Physiol Cell Physiol. 318:C1123–C1135. 2020.PubMed/NCBI View Article : Google Scholar

21 

Cancela S, Canclini L, Mourglia-Ettlin G, Hernández P and Merlino A: Neuroprotective effects of novel nitrones: In vitro and in silico studies. Eur J Pharmacol. 871(172926)2020.PubMed/NCBI View Article : Google Scholar

22 

Xu Y, Wang S, Feng L, Zhu Q, Xiang P and He B: Blockade of PKC-beta protects HUVEC from advanced glycation end products induced inflammation. Int Immunopharmacol. 10:1552–1559. 2010.PubMed/NCBI View Article : Google Scholar

23 

Xu Y, Feng L, Wang S, Zhu Q, Lin J, Lou C, Xiang P, He B, Zheng Z, Tang D, et al: Phytoestrogen calycosin-7-O-β-D-glucopyranoside ameliorates advanced glycation end products-induced HUVEC damage. J Cell Biochem. 112:2953–2965. 2011.PubMed/NCBI View Article : Google Scholar

24 

Xu Y, Feng L, Wang S, Zhu Q, Zheng Z, Xiang P, He B and Tang D: Calycosin protects HUVECs from advanced glycation end products-induced macrophage infiltration. J Ethnopharmacol. 137:359–370. 2011.PubMed/NCBI View Article : Google Scholar

25 

Leng J, Li X, Tian H, Liu C, Guo Y, Zhang S, Chu Y, Li J, Wang Y and Zhang L: Neuroprotective effect of diosgenin in a mouse model of diabetic peripheral neuropathy involves the Nrf2/HO-1 pathway. BMC Complement Med Ther. 20(126)2020.PubMed/NCBI View Article : Google Scholar

26 

Voehringer DW: BCL-2 and glutathione: Alterations in cellular redox state that regulate apoptosis sensitivity. Free Radic Biol Med. 27:945–950. 1999.PubMed/NCBI View Article : Google Scholar

27 

Scremin OU, Roch M, Norman KM, Djazayeri S and Liu YY: Brain acetylcholine and choline concentrations and dynamics in a murine model of the Fragile X syndrome: Age, sex and region-specific changes. Neuroscience. 301:520–528. 2015.PubMed/NCBI View Article : Google Scholar

28 

Zhou X, Zhu Q, Han X, Chen R, Liu Y, Fan H and Yin X: Quantitative-profiling of neurotransmitter abnormalities in the disease progression of experimental diabetic encephalopathy rat. Can J Physiol Pharmacol. 93:1007–1013. 2015.PubMed/NCBI View Article : Google Scholar

29 

Liapi C, Kyriakaki A, Zarros A, Galanopoulou P, Al-Humadi H, Dontas I, Voumvourakis K and Tsakiris S: Choline-deprivation alters crucial brain enzyme activities in a rat model of diabetic encephalopathy. Metab Brain Dis. 25:269–276. 2010.PubMed/NCBI View Article : Google Scholar

30 

Aykac A, Ozbeyli D, Uncu M, Ertaş B, Kılınc O, Şen A, Orun O and Sener G: Evaluation of the protective effect of Myrtus communis in scopolamine-induced Alzheimer model through cholinergic receptors. Gene. 689:194–201. 2019.PubMed/NCBI View Article : Google Scholar

31 

Argente-Pla M, Pérez-Lázaro A, Martinez-Millana A, Del Olmo-García MI, Espí-Reig J, Beneyto-Castello I, López-Andújar R and Merino-Torres JF: Simultaneous pancreas kidney transplantation improves cardiovascular autonomic neuropathy with improved valsalva ratio as the most precocious test. J Diabetes Res. 2020(7574628)2020.PubMed/NCBI View Article : Google Scholar

32 

Zhu X, Cheng YQ, Lu Q, Du L, Yin XX and Liu YW: Enhancement of glyoxalase 1, a polyfunctional defense enzyme, by quercetin in the brain in streptozotocin-induced diabetic rats. Naunyn Schmiedebergs Arch Pharmacol. 391:1237–1245. 2018.PubMed/NCBI View Article : Google Scholar

33 

Lu M, Xu L, Li B, Zhang W, Zhang C, Feng H, Cui X and Gao H: Protective effects of grape seed proanthocyanidin extracts on cerebral cortex of streptozotocin-induced diabetic rats through modulating AGEs/RAGE/NF-kappaB pathway. J Nutr Sci Vitaminol (Tokyo). 56:87–97. 2010.PubMed/NCBI View Article : Google Scholar

34 

Luévano-Contreras C, Gómez-Ojeda A, Macías-Cervantes MH and Garay-Sevilla ME: Dietary advanced glycation end products and cardiometabolic risk. Curr Diab Rep. 17(63)2017.PubMed/NCBI View Article : Google Scholar

35 

Singh R, Barden A, Mori T and Beilin L: Advanced glycation end-products: A review. Diabetologia. 44:129–146. 2001.PubMed/NCBI View Article : Google Scholar

36 

Gurav AN: Advanced glycation end products: A link between periodontitis and diabetes mellitus? Curr Diabetes Rev. 9:355–361. 2013.PubMed/NCBI View Article : Google Scholar

37 

Shumilina J, Kusnetsova A, Tsarev A, Janse van Rensburg HC, Medvedev S, Demidchik V, Van den Ende W and Frolov A: Glycation of plant proteins: Regulatory roles and interplay with sugar signalling? Int J Mol Sci. 20(2366)2019.PubMed/NCBI View Article : Google Scholar

38 

Bellier J, Nokin MJ, Lardé E, Karoyan P, Peulen O, Castronovo V and Bellahcène A: Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer. Diabetes Res Clin Pract. 148:200–211. 2019.PubMed/NCBI View Article : Google Scholar

39 

Dafre AL, Schmitz AE and Maher P: Methylglyoxal-induced AMPK activation leads to autophagic degradation of thioredoxin 1 and glyoxalase 2 in HT22 nerve cells. Free Radic Biol Med. 108:270–279. 2017.PubMed/NCBI View Article : Google Scholar

40 

Sung SK, Woo JS, Kim YH, Son DW, Lee SW and Song GS: Sildenafil ameliorates advanced glycation end products-induced mitochondrial dysfunction in HT-22 hippocampal neuronal cells. J Korean Neurosurg Soc. 59:259–268. 2016.PubMed/NCBI View Article : Google Scholar

41 

Li Z, Chen X, Lu W, Zhang S, Guan X, Li Z and Wang D: Anti-oxidative stress activity is essential for Amanita caesarea mediated neuroprotection on glutamate-induced apoptotic HT22 cells and an Alzheimer's disease mouse model. Int J Mol Sci. 18(E1623)2017.PubMed/NCBI View Article : Google Scholar

42 

Liu J, Li L and Suo WZ: HT22 hippocampal neuronal cell line possesses functional cholinergic properties. Life Sci. 84:267–271. 2009.PubMed/NCBI View Article : Google Scholar

43 

Singh VP, Bali A, Singh N and Jaggi AS: Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 18:1–14. 2014.PubMed/NCBI View Article : Google Scholar

44 

Chen F, Nakashima N, Kimura I and Kimura M: Hypoglycemic activity and mechanisms of extracts from mulberry leaves (folium mori) and cortex mori radicis in streptozotocin-induced diabetic mice. Yakugaku Zasshi. 115:476–482. 1995.PubMed/NCBI View Article : Google Scholar : (In Japanese).

45 

Lemus I, García R, Delvillar E and Knop G: Hypoglycaemic activity of four plants used in Chilean popular medicine. Phytother Res. 13:91–94. 1999.PubMed/NCBI View Article : Google Scholar

46 

Cai S, Sun W, Fan Y, Guo X, Xu G, Xu T, Hou Y, Zhao B, Feng X and Liu T: Effect of mulberry leaf (Folium Mori) on insulin resistance via IRS-1/PI3K/Glut-4 signalling pathway in type 2 diabetes mellitus rats. Pharm Biol. 54:2685–2691. 2016.PubMed/NCBI View Article : Google Scholar

47 

Samarghandian S, Azimi-Nezhad M and Samini F: Ameliorative effect of saffron aqueous extract on hyperglycemia, hyperlipidemia, and oxidative stress on diabetic encephalopathy in streptozotocin induced experimental diabetes mellitus. BioMed Res Int. 2014(920857)2014.PubMed/NCBI View Article : Google Scholar

48 

Jiang L, Wang J, Wang Z, Huang W, Yang Y, Cai Z and Li K: Role of the glyoxalase system in Alzheimer's disease. J Alzheimers Dis. 66:887–899. 2018.PubMed/NCBI View Article : Google Scholar

49 

Joubert M, Manrique A, Cariou B and Prieur X: Diabetes-related cardiomyopathy: The sweet story of glucose overload from epidemiology to cellular pathways. Diabetes Metab. 45:238–247. 2019.PubMed/NCBI View Article : Google Scholar

50 

Abbas GM, Abdel Bar FM, Baraka HN, Gohar AA and Lahloub MF: A new antioxidant stilbene and other constituents from the stem bark of Morus nigra L. Nat Prod Res. 28:952–959. 2014.PubMed/NCBI View Article : Google Scholar

51 

Tzavara ET, Bymaster FP, Overshiner CD, Davis RJ, Perry KW, Wolff M, McKinzie DL, Witkin JM and Nomikos GG: Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine. Mol Psychiatry. 11:187–195. 2006.PubMed/NCBI View Article : Google Scholar

52 

Kumamoto E and Kuba K: Sustained rise in ACh sensitivity of a sympathetic ganglion cell induced by postsynaptic electrical activities. Nature. 305:145–146. 1983.PubMed/NCBI View Article : Google Scholar

53 

Agatonovic-Kustrin S, Kustrin E and Morton DW: Essential oils and functional herbs for healthy aging. Neural Regen Res. 14:441–445. 2019.PubMed/NCBI View Article : Google Scholar

54 

Pandey S and Garabadu D: Piracetam facilitates the anti-amnesic but not anti-diabetic activity of metformin in experimentally induced type-2 diabetic encephalopathic rats. Cell Mol Neurobiol. 37:791–802. 2017.PubMed/NCBI View Article : Google Scholar

55 

Song IU, Chung SW, Kim YD and Maeng LS: Relationship between the hs-CRP as non-specific biomarker and Alzheimer's disease according to aging process. Int J Med Sci. 12:613–617. 2015.PubMed/NCBI View Article : Google Scholar

56 

Gregor MF and Hotamisligil GS: Inflammatory mechanisms in obesity. Annu Rev Immunol. 29:415–445. 2011.PubMed/NCBI View Article : Google Scholar

57 

Gorska-Ciebiada M, Saryusz-Wolska M, Borkowska A, Ciebiada M and Loba J: Serum levels of inflammatory markers in depressed elderly patients with diabetes and mild cognitive impairment. PLoS One. 10(e0120433)2015.PubMed/NCBI View Article : Google Scholar

58 

John CM, Mohamed Yusof NIS, Abdul Aziz SH and Mohd Fauzi F: Maternal cognitive impairment associated with gestational diabetes mellitus: A review of potential contributing mechanisms. Int J Mol Sci. 19(E3894)2018.PubMed/NCBI View Article : Google Scholar

59 

Meng Y, Wang W, Kang J, Wang X and Sun L: Role of the PI3K/AKT signalling pathway in apoptotic cell death in the cerebral cortex of streptozotocin-induced diabetic rats. Exp Ther Med. 13:2417–2422. 2017.PubMed/NCBI View Article : Google Scholar

60 

Parveen A, Kim JH, Oh BG, Subedi L, Khan Z and Kim SY: Phytochemicals: Target-based therapeutic strategies for diabetic retinopathy. Molecules. 23(E1519)2018.PubMed/NCBI View Article : Google Scholar

61 

Liang W, Zhang D, Kang J, Meng X, Yang J, Yang L, Xue N, Gao Q, Han S and Gou X: Protective effects of rutin on liver injury in type 2 diabetic db/db mice. Biomed Pharmacother. 107:721–728. 2018.PubMed/NCBI View Article : Google Scholar

62 

Butterfield DA, Di Domenico F and Barone E: Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain. Biochim Biophys Acta. 1842:1693–1706. 2014.PubMed/NCBI View Article : Google Scholar

63 

Han S, Gao H, Chen S, Wang Q, Li X, Du LJ, Li J, Luo YY, Li JX, Zhao LC, et al: Procyanidin A1 Alleviates Inflammatory Response induced by LPS through NF-κB, MAPK, and Nrf2/HO-1 Pathways in RAW264.7 cells. Sci Rep. 9(15087)2019.PubMed/NCBI View Article : Google Scholar

64 

Xu L, Botchway BOA, Zhang S, Zhou J and Liu X: Inhibition of NF-κB signaling pathway by resveratrol improves spinal cord injury. Front Neurosci. 12(690)2018.PubMed/NCBI View Article : Google Scholar

65 

Ghosh S and Hayden MS: New regulators of NF-kappaB in inflammation. Nat Rev Immunol. 8:837–848. 2008.PubMed/NCBI View Article : Google Scholar

66 

Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA and Abbott NJ: Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med. 36:592–604. 2004.PubMed/NCBI View Article : Google Scholar

67 

Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ and Rice-Evans C: Interaction between flavonoids and the blood-brain barrier: In vitro studies. J Neurochem. 85:180–192. 2003.PubMed/NCBI View Article : Google Scholar

68 

Bogush M, Heldt NA and Persidsky Y: Blood brain barrier injury in diabetes: Unrecognized effects on brain and cognition. J Neuroimmune Pharmacol. 12:593–601. 2017.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Gan W, Gao C, Zhang W, Gu J, Zhao T, Guo H, Zhou H, Xu Y, Yu L, Li L, Li L, et al: Kuwanon G protects HT22 cells from advanced glycation end product-induced damage. Exp Ther Med 21: 425, 2021.
APA
Gan, W., Gao, C., Zhang, W., Gu, J., Zhao, T., Guo, H. ... Xu, Y. (2021). Kuwanon G protects HT22 cells from advanced glycation end product-induced damage. Experimental and Therapeutic Medicine, 21, 425. https://doi.org/10.3892/etm.2021.9869
MLA
Gan, W., Gao, C., Zhang, W., Gu, J., Zhao, T., Guo, H., Zhou, H., Xu, Y., Yu, L., Li, L., Gui, D., Xu, Y."Kuwanon G protects HT22 cells from advanced glycation end product-induced damage". Experimental and Therapeutic Medicine 21.5 (2021): 425.
Chicago
Gan, W., Gao, C., Zhang, W., Gu, J., Zhao, T., Guo, H., Zhou, H., Xu, Y., Yu, L., Li, L., Gui, D., Xu, Y."Kuwanon G protects HT22 cells from advanced glycation end product-induced damage". Experimental and Therapeutic Medicine 21, no. 5 (2021): 425. https://doi.org/10.3892/etm.2021.9869
Copy and paste a formatted citation
x
Spandidos Publications style
Gan W, Gao C, Zhang W, Gu J, Zhao T, Guo H, Zhou H, Xu Y, Yu L, Li L, Li L, et al: Kuwanon G protects HT22 cells from advanced glycation end product-induced damage. Exp Ther Med 21: 425, 2021.
APA
Gan, W., Gao, C., Zhang, W., Gu, J., Zhao, T., Guo, H. ... Xu, Y. (2021). Kuwanon G protects HT22 cells from advanced glycation end product-induced damage. Experimental and Therapeutic Medicine, 21, 425. https://doi.org/10.3892/etm.2021.9869
MLA
Gan, W., Gao, C., Zhang, W., Gu, J., Zhao, T., Guo, H., Zhou, H., Xu, Y., Yu, L., Li, L., Gui, D., Xu, Y."Kuwanon G protects HT22 cells from advanced glycation end product-induced damage". Experimental and Therapeutic Medicine 21.5 (2021): 425.
Chicago
Gan, W., Gao, C., Zhang, W., Gu, J., Zhao, T., Guo, H., Zhou, H., Xu, Y., Yu, L., Li, L., Gui, D., Xu, Y."Kuwanon G protects HT22 cells from advanced glycation end product-induced damage". Experimental and Therapeutic Medicine 21, no. 5 (2021): 425. https://doi.org/10.3892/etm.2021.9869
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team